Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XBIT

XBiotech Inc

May 12 • 04:00PM ET

2.50

+0.03 1.21 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ZURA SABS XLO CABA IMUX

| Held by: VXF BSVO IWC AVSC AVUV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.49	Insider Own	36.61%	Shs Outstand	30.49M	Perf Week	-1.96%
Market Cap	76.21M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	19.32M	Perf Month	3.73%
Enterprise Value	-49.34M	PEG	-	EPS next Q	-	Inst Own	7.49%	Short Float	0.90%	Perf Quarter	3.31%
Income	-45.54M	P/S	-	EPS this Y	-	Inst Trans	-8.33%	Short Ratio	5.24	Perf Half Y	6.84%
Sales	0.00M	P/B	0.54	EPS next Y	-	ROA	-26.07%	Short Interest	0.17M	Perf YTD	4.60%
Book/sh	4.60	P/C	0.61	EPS next 5Y	-	ROE	-28.23%	52W High	3.61 -30.75%	Perf Year	-14.09%
Cash/sh	4.12	P/FCF	-	EPS past 3/5Y	-11.39% -32.63%	ROIC	-32.45%	52W Low	2.09 19.62%	Perf 3Y	-25.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	2.24% 3.17%	Perf 5Y	-82.95%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-18.10%	Oper. Margin	-	ATR (14)	0.08	Perf 10Y	-76.47%
Dividend Ex-Date	Jul 15, 2021	Quick Ratio	16.01	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	53.35	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	16.01	EPS Q/Q	-155.90%	SMA20	-0.57%	Beta	0.87	Target Price	28.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	3.92%	Rel Volume	0.92	Prev Close	2.47
Employees	85	LT Debt/Eq	0.00	Earnings	-	SMA200	-2.40%	Avg Volume	33.25K	Price	2.50
IPO	Apr 15, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	30,652	Change	1.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)